Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
1.040
-0.020 (-1.89%)
At close: Sep 18, 2026, 4:00 PM EDT
1.048
+0.008 (0.80%)
After-hours: Sep 18, 2026, 7:57 PM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $98.9 million as of September 18, 2026. Its market cap has decreased by -23.74% in one year.
Market Cap
98.90M
Enterprise Value
65.47M
1-Year Change
-23.74%
Ranking
Category
Stock Price
$1.04
ChartMarket Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $98.90M, a decrease of -61.44%. That is a compound annual growth rate of -17.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 98.90M | -17.01% |
| Dec 31, 2025 | 119.17M | 308.99% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Polaryx Therapeutics | 106.67M |
| Tenax Therapeutics | 106.54M |
| Seer, Inc. | 106.31M |
| PolyPid | 102.17M |
| Cellectis | 101.99M |
| Cardiff Oncology | 101.13M |
| Oncolytics Biotech | 98.18M |
| Atara Biotherapeutics | 97.47M |